Stratec (BATS-CHIXE:SBSD) - Stock Price, News & Analysis

SBSD Stock Overview

Designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally.

About the company

SBSD fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	4/6
Past Performance	2/6
Financial Health	3/6
Dividends	2/6

Rewards

Trading at 42.7% below our estimate of its fair value

Earnings are forecast to grow 22.04% per year

Risk Analysis

Debt is not well covered by operating cash flow

Shares are highly illiquid

Profit margins (4.8%) are lower than last year (7.5%)

Stratec SE Competitors

NIOX Group

AIM:NIOX

UK£318.0m

EKF Diagnostics Holdings

AIM:EKF

UK£149.7m

Smith & Nephew

LSE:SN.

UK£8.9b

Advanced Medical Solutions Group

AIM:AMS

UK£470.7m

Price History & Performance

Summary of all time highs, changes and price drops for Stratec
Historical stock prices
Current Share Price	€39.10
52 Week High	€50.50
52 Week Low	€39.10
Beta	0.11
1 Month Change	0%
3 Month Change	-9.60%
1 Year Change	-38.03%
3 Year Change	-65.34%
5 Year Change	-36.32%
Change since IPO	-26.64%

Recent updates

Shareholder Returns

	SBSD	GB Medical Equipment	GB Market
7D	0%	0.8%	1.0%
1Y	-38.0%	-10.7%	6.7%

Return vs Industry: SBSD underperformed the UK Medical Equipment industry which returned -10.7% over the past year.

Return vs Market: SBSD underperformed the UK Market which returned 6.7% over the past year.

Price Volatility

Is SBSD's price volatile compared to industry and market?
SBSD volatility
SBSD Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.9%
Market Average Movement	4.9%
10% most volatile stocks in GB Market	11.3%
10% least volatile stocks in GB Market	2.7%

Stable Share Price: SBSD has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine SBSD's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1979	1,473	Marcus Wolfinger	www.stratec.com

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.

Stratec SE Fundamentals Summary

How do Stratec's earnings and revenue compare to its market cap?
SBSD fundamental statistics
Market cap	€533.65m
Earnings (TTM)	€12.15m
Revenue (TTM)	€252.30m

43.9x

P/E Ratio

2.1x

P/S Ratio

Is SBSD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SBSD income statement (TTM)
Revenue	€252.30m
Cost of Revenue	€187.71m
Gross Profit	€64.60m
Other Expenses	€52.45m
Earnings	€12.15m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 09, 2024

Earnings per share (EPS)	1.00
Gross Margin	25.60%
Net Profit Margin	4.81%
Debt/Equity Ratio	62.0%

How did SBSD perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

55%

Payout Ratio

Does SBSD pay a reliable dividends?

See SBSD dividend history and benchmarks

When do you need to buy SBSD by to receive an upcoming dividend?
Stratec dividend dates
Ex Dividend Date	May 20 2024
Dividend Pay Date	May 22 2024
Days until Ex dividend	2 days
Days until Dividend pay date	4 days